https://jods.online/index.php/jods/issue/feedThe Journal of One-Day Surgery2024-02-26T19:05:45+00:00Andrei Tanasejods@bads.co.ukOpen Journal Systems<p>The<em> Journal of One-Day Surgery</em> (JODS) is the flagship publication of the British Association of Day Surgery. JODS publishes original articles including research trials, case series, case reports and service improvement project reports. Unlike many national publications, JODS is still able to offer citable peer-reviewed publication with no author processing fees. It also commissions featured articles, for example the 'How I do it' series detailing how high-performing day surgery units achieve the highest day surgery rates for specific procedures. JODS also brings you news of relevant forthcoming national meetings and provides summary reports of recent day surgery meetings hosted by BADS.</p> <p> </p> <p><strong>Who funds JODS?</strong></p> <p>Publication infrastructure and maintenance of JODS is fully supported by <a href="https://bads.co.uk/">British Association of Day Surgery(BADS)</a>, driven by the belief that publishing peer-reviewed information is key to improving day-case surgery. JODS aims to make day-case surgery research available:</p> <ul> <li>online</li> <li>peer-reviewed</li> <li>without publishing charges</li> </ul>https://jods.online/index.php/jods/article/view/94Evaluation of an ambulatory abscess pathway in a district general hospital and the impact of COVID on ensuring long term compliance.2023-10-25T17:39:15+00:00Kalyani Nairknair92@hotmail.comMoneet Gillmoneetgill@gmail.comDinesh Balasubramaniambaladeep@hotmail.com<p>Introduction</p> <p>Superficial skin abscesses are common and can lead to significant illness if not managed promptly. The gold standard treatment is incision and drainage (I&D), as, often antibiotics alone do not lead to resolution. This multi-cycle retrospective study audits the practice in a district general hospital by assessing the efficiency of a day case abscess pathway. </p> <p>Methods</p> <p>Phase 1 established standards for creating the pathway by streamlining patients to be operated on dedicated days, phase 2 evaluated the effect on waiting times for I&D, and phase 3 assessed the efficacy of the pathway after the impact of COVID. Data collected includes gender, age, comorbidities, time of admission to the surgical assessment unit, time sent for by theatre, anaesthetic agent, and discharge date.</p> <p>Results</p> <p>Phase 1 was conducted from 2017 to 2018, included 87 cases, and the average wait time was 8 hours 29 minutes for I&D. Phase 2 included 32 cases from August to October 2019, showed an average wait of 4 hours 43 minutes with 2 patients requiring overnight admission. Phase 3 included 208 patients from January to December 2022, showed an average wait of 4 hours 55 minutes with 21% requiring an unplanned overnight admission.</p> <p>Conclusion</p> <p>This study showed that there is significant benefit of a day case abscess pathway. It leads to fewer admissions, improving patient satisfaction and saving money for hospital trusts. There needs to be strict criteria to ensure that appropriate patients are triaged to them. This will require ongoing refinement and both medical and nursing staff education.</p>2024-02-26T00:00:00+00:00Copyright (c) 2024 The Journal of One-Day Surgeryhttps://jods.online/index.php/jods/article/view/9630-day readmission rate following laparoscopic cholecystectomy in North Devon District Hospital over a three-year period – a closed loop audit2024-01-17T10:09:14+00:00Abidemi Adesuyia.adesuyi@nhs.netDavid Buntingdavidbunting@nhs.net<p><strong><span style="color: black;">Introduction</span></strong></p> <p style="text-align: justify;"><span style="color: black;">Laparoscopic cholecystectomy is the most performed hepatobiliary procedure in the United Kingdom and worldwide. Readmission rate following surgery is considered a key performance indicator and care quality measure. Reducing this will allow for effective cost savings in the National Health Service. The aim was to determine 30-day readmission rate post-laparoscopic cholecystectomy, identify the indications for readmission and reduce this rate.</span></p> <p><strong><span style="color: black;">Methods</span></strong></p> <p style="text-align: justify;"><span style="color: black;">From a database of consecutive patients undergoing cholecystectomy over a 3-year period between 2019-2021, data on demography, comorbidity, and 30-day readmission rates over three separate time periods were extracted and evaluated. Findings were presented at the local departmental governance meeting after each audit round. Recommendations including introducing a standardised post-operative analgesia protocol were made and implemented prior to re-audit.</span></p> <p><strong><span style="color: black;">Results</span></strong></p> <p style="text-align: justify;"><span style="color: black;">A total of 883 patients had laparoscopic cholecystectomy: 69% females and 31% males. 70% were performed as day case. Overall readmission rate was 6% (5%; day case and 6%; overnight-cases). Readmission rates were 4%, 6% and 6% for years 2019, 2020 and 2021 respectively. Indications for readmission were biliary in 22% and non-biliary in 78%. Common indications for readmission were abdominal pain, postoperative infection, retained stone and pancreatitis. Non-specific abdominal pain was the commonest indication. Following adjustment for comorbidity; increasing age and male gender were associated with an increased rate for admission.</span></p> <p><strong><span style="color: black;">Conclusion</span></strong></p> <p style="text-align: justify;"><span style="color: black;">Readmission rates following laparoscopic cholecystectomy in North Devon District Hospital over a three-year period were less than 10% in accordance with Association of Upper Gastrointestinal Surgeons standards. Standards have been maintained following a re-audit.</span></p>2024-02-26T00:00:00+00:00Copyright (c) 2024 The Journal of One-Day Surgeryhttps://jods.online/index.php/jods/article/view/98President's Letter JODS 34.12024-02-26T18:42:09+00:00David Buntingpresident@bads.co.uk2024-02-26T00:00:00+00:00Copyright (c) 2024 The Journal of One-Day Surgeryhttps://jods.online/index.php/jods/article/view/99 Editor-in-Chief Letter JODS 34.12024-02-26T18:43:12+00:00Andrei Tanasejods@bads.co.uk2024-02-26T00:00:00+00:00Copyright (c) 2024 The Journal of One-Day Surgeryhttps://jods.online/index.php/jods/article/view/97Experience of introducing the UroLift System to the Urological Investigations Unit2024-02-26T18:22:03+00:00Nicolas BryanLynda.Guckian@teleflex.com<p>This article is sponsored by Teleflex</p>2024-02-26T00:00:00+00:00Copyright (c) 2024 The Journal of One-Day Surgery